Clinical Trial Update: A Study of EMB-02 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial of EMB-02 for advanced solid tumors (Phase 1/2) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• EMB-02 (EMB-02)

Snippet

Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: TERMINATED